Monthly Archives: February 2013
IOM: Curb Fake Meds through Track-and-Trace, but Forget "Counterfeits"
A new report from the Institute of Medicine (IOM) has drawn a lot of attention to the public health dangers of falsified and substandard medicines around the world. The aim is to build support for a range of activities that can limit the spread of fake medicines in the U.S. and help developing nations strengthen [...]
Should CEOs Use Social Media?
Yes, writes Peter Houston, but you don’t have to do it all yourself.
You probably have bigger calls on your time, but have you given much thought to social media? Not in the abstract corporate communications sense, in a you-the-CEO sense? There has been a flurry of reports over the last six months about the C-suite’s [...]
Pharma's Most Productive Innovators: The Top Ten
By Stephanie Sutton, PharmTech Europe.
Consultancy firm IDEA Pharma has released what it calls a ‘Productive Innovation Index’, which ranks pharmaceutical companies based on their ability to successfully commercialize new innovations. The company has been published the index for three years and uses publicly available data to reach its conclusions.
Although the index [...]

Daiichi Sankyo Faces Gender Discrimination Lawsuit